Gang Zheng

Dr. Gang Zheng, M.D., Ph.D., is a Professor of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota. He serves as a Consultant in the Division of Laboratory Genetics and Genomics and holds a joint appointment in the Department of Clinical Genomics. Dr. Zheng is board certified in both molecular pathology and hematopathology, and serves as co-director of Mayo Clinical Genomics Laboratory.

• 2015: Fellowship in Molecular Pathology, Johns Hopkins Hospital
• 2014: Residency in Anatomic and Clinical Pathology, Johns Hopkins Hospital
• 2013: Fellowship in Hematopathology, Johns Hopkins Hospital
• 2012: Residency in Anatomic and Clinical Pathology, Johns Hopkins Hospital
• 2009: Post Doctoral Fellowship, Harvard Medical School
• 2005: Ph.D., Case Western Reserve University
• 1997: M.D., Beijing Medical University

Dr. Zheng's research focuses on implementing cutting-edge molecular technologies in clinical diagnostics of cancer, particularly liquid biopsy approaches using circulating cell-free DNA (cfDNA) cancer tests based on next-generation sequencing. His work emphasizes the integration of genomic, morphologic, and clinical data to improve clinical decision-making and interpretation of molecular tests. He applies data mining techniques to identify clinically relevant disease entities based on genomic markers and to enhance the clinical utility of genomics and epigenetic markers in oncology.

Analysis of Dr. Zheng's recent publications reveals a strong focus on molecular diagnostics in hematologic malignancies, particularly myeloid neoplasms, leukemias, and lymphomas. His work spans technical advancements in next-generation sequencing, clinical applications of genomic testing, and the development of classification systems for hematologic disorders. A significant portion of his research addresses diagnostic challenges and pitfalls in hematopathology, with emphasis on molecular markers that improve diagnostic accuracy and clinical correlation.

Scientific Awards

• Grant awardee, The Women's Board, Johns Hopkins University (2018)
• Clinical Pathology Teaching Award, Johns Hopkins University (2017)
• Achievement in Quality Improvement, Johns Hopkins University (2017)
• Awardee, global health faculty pilot grant, Johns Hopkins University (2016)
• Young Investigator's Award, Johns Hopkins University (2013)
• Eggleston research award, Johns Hopkins University (2011)
• Best Presentation award, Case Western Reserve University (2004)

Dr. Zheng has been actively involved in professional organizations and editorial work, serving on the editorial board of the Journal of Applied Laboratory Medicine since 2019 and as a Review Editor for Hematologic Malignancies at Frontiers in Oncology since 2020. He has held leadership positions including Vice Chair of the Molecular Analysis Committee of the International Society for Laboratory Hematology (2020-present) and Expert Adviser for Molecular Diagnostics at the Clinical and Laboratory Standards Institute (2020-present).

As co-director of the Mayo Clinical Genomics Laboratory, Dr. Zheng leads a team focused on implementing and validating advanced molecular diagnostic tests. His laboratory work emphasizes the clinical application of next-generation sequencing technologies and the development of novel approaches for cancer diagnostics, particularly in hematologic malignancies.